News
In June 2022, Enanta filed a lawsuit against Pfizer in a US district court in Massachusetts, claiming that the big pharma ...
Madrigal Pharmaceuticals’ Rezdiffra has been approved in Europe for the treatment of MASH with moderate to advanced liver ...
Bristol Myers Squibb and SystImmune have announced breakthrough therapy designation from the US Food and Drug Administration ...
The FDA has rejected vatiquinone, requesting that PTC run an additional study to prove the drug's efficacy prior to ...
Biotechnology company āshibio has entered an exclusive licensing agreement with Mereo BioPharma for the monoclonal antibody, ...
Viking's obesity pill VK2735 met its primary endpoint but failed to outdo competitors Novo Nordisk and Eli Lilly in body ...
Novo is far from the only big pharma company bolstering DTC medicine offerings. Novo’s main rival in the GLP-1RA arena, Eli ...
Santen has signed an agreement with RemeGen for the RC28-E intravitreal injection, a dual-target fusion protein for retinal ...
The European Commission (EC) has granted marketing authorisation to SpringWorks Therapeutics, a subsidiary of Merck KGaA, for ...
Every aspect of science and research is based on data, and across the globe, labs are producing more data than the average ...
Clinical supply chains are transforming, and so are the technological barriers to entry for firms in Life Sciences. To stay ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results